CAMBIUM BIO LIMITED - Announcements

4.21%

49.5¢

Market Cap $11.31M

Healthcare Biotechnology

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Announcements

Filter Results

All Price Sensitive Only

CMB	Cambium Bio Signs Strategic MoU with Benta SAS	PRICE SENSITIVE	05/09/25	147.77KB	Share
CMB	Cambium Bio Signs US$2.0M plus Licensing Deal	PRICE SENSITIVE	02/09/25	145.57KB	Share
CMB	FY25 Appendix 4G and Corporate Governance Statement		29/08/25	680.44KB	Share
CMB	FY25 Appendix 4E and Annual Report	PRICE SENSITIVE	29/08/25	1.8MB	Share
CMB	Cleansing notice		29/08/25	114.06KB	Share
CMB	Application for quotation of securities - CMB		29/08/25	15.67KB	Share
CMB	Update - Proposed issue of securities - CMB		27/08/25	15.96KB	Share
CMB	Placement Participant Update	PRICE SENSITIVE	27/08/25	121.13KB	Share
CMB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/25	274.3KB	Share
CMB	Proposed issue of securities - CMB		30/07/25	16.01KB	Share
CMB	Cambium Bio Raises A$2.12 million	PRICE SENSITIVE	30/07/25	114.73KB	Share
CMB	Cambium Bio Clears FDA Regulatory Hurdles		11/07/25	108.46KB	Share
CMB	Cambium Bio Receives Ethics Approvals		30/06/25	135.38KB	Share
CMB	Change of Address		23/05/25	83.46KB	Share
CMB	Initial Director's Interest Notice - Denese Marks		22/05/25	183.14KB	Share
CMB	Final Director's Interest Notice - Barry Sechos		22/05/25	183.54KB	Share
CMB	Board and Company Secretary Changes		21/05/25	146.97KB	Share
CMB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/25	259.75KB	Share
CMB	Change of registry address		14/04/25	64.39KB	Share
CMB	Notice of ceasing to be a substantial holder		11/04/25	268.2KB	Share
CMB	Cambium Bio - Release of Shares from Escrow		21/03/25	62.88KB	Share
CMB	Notice of change of interests of substantial holder-CMB		18/03/25	308.39KB	Share
CMB	FDA Approves Cambium Bio's Potency Assay Strategy for Elate		18/03/25	77.51KB	Share
CMB	Change of Directors Interest Notice		12/03/25	458.81KB	Share
CMB	Notification regarding unquoted securities - CMB		12/03/25	14.3KB	Share
CMB	Application for quotation of securities - CMB		12/03/25	15.41KB	Share
CMB	Mr Chiu - Director Appointment and Appedix 3X		07/03/25	262.31KB	Share
CMB	Results of General Meeting		04/03/25	151.06KB	Share
CMB	Response to queries re Appendices 3X and 3Z		03/03/25	64.9KB	Share
CMB	Update - Proposed issue of securities - CMB		28/02/25	15.76KB	Share
CMB	Half Year Report and Accounts	PRICE SENSITIVE	27/02/25	1.88MB	Share
CMB	FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol	PRICE SENSITIVE	25/02/25	99.64KB	Share
CMB	Final Director Interest Notice-Graham Vesey		17/02/25	190.96KB	Share
CMB	Initial and Final Director Interest Notices-Chandra Bala		17/02/25	275.88KB	Share
CMB	Placement Shares Cleansing Notice		13/02/25	94.21KB	Share
CMB	Application for quotation of securities - CMB		13/02/25	15.64KB	Share
CMB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	374.03KB	Share
CMB	Notice of General Meeting/Proxy Form		30/01/25	1.33MB	Share
CMB	Change in substantial holding		07/01/25	3.23MB	Share
CMB	Placement Shares Cleansing Notice		12/12/24	137.79KB	Share
CMB	Application for quotation of securities - CMB		12/12/24	15.68KB	Share
CMB	FDA Grants Fast Track Designation		09/12/24	109.62KB	Share
CMB	Proposed issue of securities - CMB		05/12/24	15.78KB	Share
CMB	Cambium Bio Successfully Closes A$3.0M Financing Round	PRICE SENSITIVE	05/12/24	81.86KB	Share
CMB	Trading Halt	PRICE SENSITIVE	02/12/24	532.02KB	Share
CMB	AGM results and Re-appointment of Dr Bala		26/11/24	361.41KB	Share
CMB	Cambium AGM CEO address		26/11/24	1.93MB	Share
CMB	Proposed issue of securities - CMB		22/11/24	14.23KB	Share
CMB	Cambium Bio Board Changes		22/11/24	77.62KB	Share
CMB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/24	427.56KB	Share
CMB	Notice of Annual General Meeting/Proxy Form		25/10/24	462.14KB	Share
CMB	CEO Acquires Shares Demonstrating Strong Confidence		15/10/24	71.93KB	Share
CMB	Initial Director's Interest Notice - Chang		10/10/24	230.01KB	Share
CMB	Cambium Bio Strengthens Leadership with Two Key Appointments		10/10/24	70.58KB	Share
CMB	Date of AGM		02/10/24	235.82KB	Share
CMB	CEO Revised Engagement Agreement Terms		30/08/24	72.33KB	Share
CMB	Appendix 4G and Corporate Governance Statement		30/08/24	456.36KB	Share
CMB	Cambium 4E and Annual Report	PRICE SENSITIVE	30/08/24	3.52MB	Share
CMB	Change in substantial holding-Apex		31/07/24	99.73KB	Share
CMB	Change in substantial holding-Treasure		31/07/24	107.57KB	Share
CMB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	284.86KB	Share
CMB	Change in substantial holding		19/07/24	253.99KB	Share
CMB	Change of Directors Interest		12/07/24	475.53KB	Share
CMB	Completion of Share Consolidation		12/07/24	122.18KB	Share
CMB	Notification of cessation of securities - CMB		09/07/24	12.71KB	Share
CMB	Change in substantial holding		04/07/24	66.19KB	Share
CMB	Change in substantial holding-Treasure		02/07/24	228.3KB	Share
CMB	Change in substantial holding-Apex		02/07/24	270.9KB	Share
CMB	Becoming a substantial holder-Treasure		02/07/24	137.18KB	Share
CMB	Becoming a substantial holder-Apex		02/07/24	252.41KB	Share
CMB	Change of Director's Interest Notice		01/07/24	230.5KB	Share
CMB	Placement Shares Cleansing Notice		28/06/24	215.4KB	Share
CMB	Application for quotation of securities - CMB		28/06/24	15.41KB	Share
CMB	Results of Meeting		25/06/24	190.81KB	Share
CMB	Correction to Notice of General Meeting		13/06/24	136.29KB	Share
CMB	Notice of Share Consolidation		23/05/24	64.82KB	Share
CMB	Consolidation/Split - CMB		23/05/24	14.5KB	Share
CMB	Letter to Shareholders		23/05/24	157.5KB	Share
CMB	Notice of General Meeting/Proxy Form	PRICE SENSITIVE	23/05/24	2.04MB	Share
CMB	Becoming a substantial holder - Cyntec		14/05/24	323.07KB	Share
CMB	Becoming a substantial holder - ZYBT		14/05/24	1.07MB	Share
CMB	Response to ASX Aware Query	PRICE SENSITIVE	01/05/24	800.58KB	Share
CMB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	339.14KB	Share
CMB	Change in substantial holding		11/04/24	282.87KB	Share
CMB	Initial Director's Interest Notice - Tseng		11/04/24	238.05KB	Share
CMB	Director Appointment Dr. Tseng		11/04/24	64.58KB	Share
CMB	Placement Shares Cleansing Notice		10/04/24	182.72KB	Share
CMB	Application for quotation of securities - CMB		10/04/24	15.66KB	Share
CMB	Proposed issue of securities - RGS		08/04/24	15.93KB	Share
CMB	Ceasing to be a substantial holder - Kirman 2		08/04/24	258.93KB	Share
CMB	Ceasing to be a substantial holder - Lee		08/04/24	563.88KB	Share
CMB	Ceasing to be a substantial holder - Vesey		08/04/24	91.93KB	Share
CMB	Change of Company Name and ASX Code		08/04/24	109.76KB	Share
CMB	Cambium Bio Raises A$3.48 Million in Strategic Placement	PRICE SENSITIVE	05/04/24	170.74KB	Share
CMB	Final Director's Interest Notice - Leo Lee		05/04/24	241.91KB	Share
CMB	Director Resignation - Leo Lee		05/04/24	113.78KB	Share
CMB	Notice of initial substantial holder		05/04/24	796.8KB	Share
CMB	Initial Director's Interest Notice - Waller		05/04/24	248.24KB	Share
CMB	Initial Director's Interest Notice - Walts		05/04/24	247.86KB	Share
CMB	Consideration Shares Cleansing Notice		05/04/24	218.8KB	Share

CMB Cambium Bio Signs Strategic MoU with Benta SAS
05/09/25	PRICE SENSITIVE	147.77KB	Share
CMB Cambium Bio Signs US$2.0M plus Licensing Deal
02/09/25	PRICE SENSITIVE	145.57KB	Share
CMB FY25 Appendix 4G and Corporate Governance Statement
29/08/25		680.44KB	Share
CMB FY25 Appendix 4E and Annual Report
29/08/25	PRICE SENSITIVE	1.8MB	Share
CMB Cleansing notice
29/08/25		114.06KB	Share
CMB Application for quotation of securities - CMB
29/08/25		15.67KB	Share
CMB Update - Proposed issue of securities - CMB
27/08/25		15.96KB	Share
CMB Placement Participant Update
27/08/25	PRICE SENSITIVE	121.13KB	Share
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/07/25	PRICE SENSITIVE	274.3KB	Share
CMB Proposed issue of securities - CMB
30/07/25		16.01KB	Share
CMB Cambium Bio Raises A$2.12 million
30/07/25	PRICE SENSITIVE	114.73KB	Share
CMB Cambium Bio Clears FDA Regulatory Hurdles
11/07/25		108.46KB	Share
CMB Cambium Bio Receives Ethics Approvals
30/06/25		135.38KB	Share
CMB Change of Address
23/05/25		83.46KB	Share
CMB Initial Director's Interest Notice - Denese Marks
22/05/25		183.14KB	Share
CMB Final Director's Interest Notice - Barry Sechos
22/05/25		183.54KB	Share
CMB Board and Company Secretary Changes
21/05/25		146.97KB	Share
CMB Quarterly Activities/Appendix 4C Cash Flow Report
28/04/25	PRICE SENSITIVE	259.75KB	Share
CMB Change of registry address
14/04/25		64.39KB	Share
CMB Notice of ceasing to be a substantial holder
11/04/25		268.2KB	Share
CMB Cambium Bio - Release of Shares from Escrow
21/03/25		62.88KB	Share
CMB Notice of change of interests of substantial holder-CMB
18/03/25		308.39KB	Share
CMB FDA Approves Cambium Bio's Potency Assay Strategy for Elate
18/03/25		77.51KB	Share
CMB Change of Directors Interest Notice
12/03/25		458.81KB	Share
CMB Notification regarding unquoted securities - CMB
12/03/25		14.3KB	Share
CMB Application for quotation of securities - CMB
12/03/25		15.41KB	Share
CMB Mr Chiu - Director Appointment and Appedix 3X
07/03/25		262.31KB	Share
CMB Results of General Meeting
04/03/25		151.06KB	Share
CMB Response to queries re Appendices 3X and 3Z
03/03/25		64.9KB	Share
CMB Update - Proposed issue of securities - CMB
28/02/25		15.76KB	Share
CMB Half Year Report and Accounts
27/02/25	PRICE SENSITIVE	1.88MB	Share
CMB FDA Approves Elate Ocular Phase 3 Clinical Trial Protocol
25/02/25	PRICE SENSITIVE	99.64KB	Share
CMB Final Director Interest Notice-Graham Vesey
17/02/25		190.96KB	Share
CMB Initial and Final Director Interest Notices-Chandra Bala
17/02/25		275.88KB	Share
CMB Placement Shares Cleansing Notice
13/02/25		94.21KB	Share
CMB Application for quotation of securities - CMB
13/02/25		15.64KB	Share
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	374.03KB	Share
CMB Notice of General Meeting/Proxy Form
30/01/25		1.33MB	Share
CMB Change in substantial holding
07/01/25		3.23MB	Share
CMB Placement Shares Cleansing Notice
12/12/24		137.79KB	Share
CMB Application for quotation of securities - CMB
12/12/24		15.68KB	Share
CMB FDA Grants Fast Track Designation
09/12/24		109.62KB	Share
CMB Proposed issue of securities - CMB
05/12/24		15.78KB	Share
CMB Cambium Bio Successfully Closes A$3.0M Financing Round
05/12/24	PRICE SENSITIVE	81.86KB	Share
CMB Trading Halt
02/12/24	PRICE SENSITIVE	532.02KB	Share
CMB AGM results and Re-appointment of Dr Bala
26/11/24		361.41KB	Share
CMB Cambium AGM CEO address
26/11/24		1.93MB	Share
CMB Proposed issue of securities - CMB
22/11/24		14.23KB	Share
CMB Cambium Bio Board Changes
22/11/24		77.62KB	Share
CMB Quarterly Activities/Appendix 4C Cash Flow Report
30/10/24	PRICE SENSITIVE	427.56KB	Share
CMB Notice of Annual General Meeting/Proxy Form
25/10/24		462.14KB	Share
CMB CEO Acquires Shares Demonstrating Strong Confidence
15/10/24		71.93KB	Share
CMB Initial Director's Interest Notice - Chang
10/10/24		230.01KB	Share
CMB Cambium Bio Strengthens Leadership with Two Key Appointments
10/10/24		70.58KB	Share
CMB Date of AGM
02/10/24		235.82KB	Share
CMB CEO Revised Engagement Agreement Terms
30/08/24		72.33KB	Share
CMB Appendix 4G and Corporate Governance Statement
30/08/24		456.36KB	Share
CMB Cambium 4E and Annual Report
30/08/24	PRICE SENSITIVE	3.52MB	Share
CMB Change in substantial holding-Apex
31/07/24		99.73KB	Share
CMB Change in substantial holding-Treasure
31/07/24		107.57KB	Share
CMB Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	284.86KB	Share
CMB Change in substantial holding
19/07/24		253.99KB	Share
CMB Change of Directors Interest
12/07/24		475.53KB	Share
CMB Completion of Share Consolidation
12/07/24		122.18KB	Share
CMB Notification of cessation of securities - CMB
09/07/24		12.71KB	Share
CMB Change in substantial holding
04/07/24		66.19KB	Share
CMB Change in substantial holding-Treasure
02/07/24		228.3KB	Share
CMB Change in substantial holding-Apex
02/07/24		270.9KB	Share
CMB Becoming a substantial holder-Treasure
02/07/24		137.18KB	Share
CMB Becoming a substantial holder-Apex
02/07/24		252.41KB	Share
CMB Change of Director's Interest Notice
01/07/24		230.5KB	Share
CMB Placement Shares Cleansing Notice
28/06/24		215.4KB	Share
CMB Application for quotation of securities - CMB
28/06/24		15.41KB	Share
CMB Results of Meeting
25/06/24		190.81KB	Share
CMB Correction to Notice of General Meeting
13/06/24		136.29KB	Share
CMB Notice of Share Consolidation
23/05/24		64.82KB	Share
CMB Consolidation/Split - CMB
23/05/24		14.5KB	Share
CMB Letter to Shareholders
23/05/24		157.5KB	Share
CMB Notice of General Meeting/Proxy Form
23/05/24	PRICE SENSITIVE	2.04MB	Share
CMB Becoming a substantial holder - Cyntec
14/05/24		323.07KB	Share
CMB Becoming a substantial holder - ZYBT
14/05/24		1.07MB	Share
CMB Response to ASX Aware Query
01/05/24	PRICE SENSITIVE	800.58KB	Share
CMB Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	339.14KB	Share
CMB Change in substantial holding
11/04/24		282.87KB	Share
CMB Initial Director's Interest Notice - Tseng
11/04/24		238.05KB	Share
CMB Director Appointment Dr. Tseng
11/04/24		64.58KB	Share
CMB Placement Shares Cleansing Notice
10/04/24		182.72KB	Share
CMB Application for quotation of securities - CMB
10/04/24		15.66KB	Share
CMB Proposed issue of securities - RGS
08/04/24		15.93KB	Share
CMB Ceasing to be a substantial holder - Kirman 2
08/04/24		258.93KB	Share
CMB Ceasing to be a substantial holder - Lee
08/04/24		563.88KB	Share
CMB Ceasing to be a substantial holder - Vesey
08/04/24		91.93KB	Share
CMB Change of Company Name and ASX Code
08/04/24		109.76KB	Share
CMB Cambium Bio Raises A$3.48 Million in Strategic Placement
05/04/24	PRICE SENSITIVE	170.74KB	Share
CMB Final Director's Interest Notice - Leo Lee
05/04/24		241.91KB	Share
CMB Director Resignation - Leo Lee
05/04/24		113.78KB	Share
CMB Notice of initial substantial holder
05/04/24		796.8KB	Share
CMB Initial Director's Interest Notice - Waller
05/04/24		248.24KB	Share
CMB Initial Director's Interest Notice - Walts
05/04/24		247.86KB	Share
CMB Consideration Shares Cleansing Notice
05/04/24		218.8KB	Share

REFRESH

1 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 49.5¢		Change 0.020(4.21%)		Mkt cap ! $11.31M

Open	High	Low	Value	Volume
47.5¢	55.0¢	46.5¢	$41.36K	86.73K

Buyers (Bids)

No.	Vol.	Price($)
1	4426	51.0¢

Sellers (Offers)

Price($)	Vol.	No.
52.0¢	402	1

View Market Depth

No.	Vol.	Price($)
1	4426	0.510
1	100000	0.500
1	250	0.495
1	2145	0.465
1	1100	0.460

Price($)	Vol.	No.
0.520	402	1
0.540	3488	1
0.545	4500	1
0.550	196620	1
0.560	1500	1

Last trade - 12.52pm 05/09/2025 (20 minute delay)

CMB (ASX) Chart

CAMBIUM BIO LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories